GRAL Wutah bathi saben saham ing taun lumaku grail.com

Simbol resmi perusahaan GRAIL, Inc. (GRAL)

Integrating tests into corporate insurance ensures clinic loyalty, which illustrates the percentage growth rate of GRAIL, Inc. (GRAL) earnings per share YoY. The value of 13.80 shows the latest reading of this trend. Success is based on unique Galleri patents and strict FDA control. Growth is driven by the commercial implementation of blood analysis and potential recognition by Medicare as a diagnostic standard.

Wutah bathi saben saham ing taun lumaku: GRAIL Corp (GRAL) kanggo 29.06.2024 - 12.11.2026

Rincian analitis lan laporan data perusahaan GRAIL, Inc. (GRAL)

- nilai pasar lan prakiraan target analis:
Rega saham GRAIL Inc|GRAL - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar GRAIL Bio|GRAL - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- indikator kapitalisasi buku:
Nilai Aset Bersih saben Saham GRAIL|GRAL - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku grail.com|GRAL - Total Aset Perusahaan
- informasi babagan utang lan solvabilitas:
Koefisien Total Utang marang Modal GRAIL, Inc.|GRAL - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal grail.com|GRAL - Gunggung utang perusahaan|Utang marang aset resik GRAIL Bio|GRAL - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan GRAIL|Rasio cepet grail.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
GRAL - Bathi resik|Prakiraan bathi perusahaan GRAIL, Inc.|GRAL - Rasio rega marang bathi|Rega marang bathi mangsa ngarep GRAIL Bio|GRAL - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan GRAIL Bio|GRAL - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan GRAIL|GRAL - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan grail.com|GRAL - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep GRAIL, Inc.
Pambiji fundamental:GRAL (GRAIL Inc)
Produk seri GRAIL

For the multi-cancer screening leader GRAIL, Inc. (GRAL), the current YoY EPS growth rate serves as an indicator of the efficiency of monetizing unique clinical data under strict regulatory control. This metric measures the annual dynamics of earnings per share, allowing for an assessment of the business's ability to scale profitability faster than inflationary costs, which determines the company's long-term investment attractiveness.

Pesaing utama

Caris Life Sciences Inc (CAI) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku Guardant360|Wutah bathi saben saham ing taun lumaku VCYT|Wutah bathi resik saben saham ing taun iki CELC (Celcuity Inc.)|MYGN - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Castle Biosciences, Inc. CSTL|Prakiraan wutah bathi resik saben saham ing taun iki Burning Rock Biotech Limited (BNR)|VolitionRx Ltd - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Biodesix Corporation BDSX|Precipio, Inc. (PRPO) - Wutah bathi saben saham ing taun lumaku|CHEK - Prakiraan wutah bathi resik saben saham ing taun iki|MYNZ (Mainz Biomed) - Wutah bathi ing taun lumaku|OCX - Owah-owahan bathi resik saben saham ing taun lumaku